Key result
Sequence analyses of the VP7 gene in eight rotavirus vaccine recipients revealed five amino acid substitutions, including two at aa123, which did not cause clinical symptoms or reversion of pathogenicity.
Why the study?
Rotarix strains replicate and shed for about one month, prompting this study to identify genetic changes in shed strains to reveal significant mutations and their clinical impact on recipients.
Observational (n=8)
No
This is the authors' abstract. We don't add key points for this paper.
Strains of Rotarix, a live attenuated monovalent oral rotavirus vaccine, replicate in the intestine and are shed for about one month in immunocompetent recipients. The current study aimed to identify genetic changes of shed strains to reveal any significant mutations and their clinical impact on recipients. Stool samples of recipients of the first dose of Rotarix were sequentially collected for one month from the day of administration. Sequence analyses of the VP7 gene in eight recipients revealed five amino acid substitutions. Among them, two were observed in aa123, which is located in antigenic region 7-1a. Since there were no associated clinical symptoms, the genetic changes were unlikely to have caused reversion of pathogenicity of vaccine strain. Of interest, the virus in one case became closer to wild-type rotavirus via an amino acid change at aa123 occurring 14 days after administration, which might have resulted from multiple replications and long-term shedding of the vaccine strain.
Answers are grounded in this paper and cite their sources.
Shed Rotarix vaccine strains undergo minor genetic changes in the VP7 gene during replication in healthy infants, but these mutations do not cause reversion to pathogenicity or clinical symptoms.
No takes yet. Share an insight, caveat, or question.
Kaneko et al. (2019) conducted an observational in Rotavirus vaccine shedding (n=8). Rotarix (monovalent rotavirus vaccine) was evaluated on Nucleotide mutations and amino acid substitutions in the VP7 gene of shed Rotarix strains. Sequence analyses of the VP7 gene in eight rotavirus vaccine recipients revealed five amino acid substitutions, including two at aa123, which did not cause clinical symptoms or reversion of pathogenicity.
Synapse has enriched 10 related papers. Consider them for comparative context: